Delays of study results leading to a delay of a regulatory approval assuming that another competitor like CAR-T with a later approval and launch date may prove more efficient than earlier drugs and thereby significantly reduce the market potential of the earlier drugs
How does GBM AGILE work?, page-28
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)